| Methods |
Multi centre, randomized, double blind placebo controlled study |
| Participants |
Country: Italy
Multicentre
Selection criteria:
Probable Alzheimer's Disease (AD) as specified by NINCDS‐ADRDA criteria
Mean age : subjects 69.8+/‐8.5y, controls 71.1+/‐ 8.0
137 patients (91 males, 46 females) |
| Interventions |
1.ALC 2g/day for 180 days
2. Placebo for 180 days |
| Outcomes |
Digit span, block tapping, verbal fluency, copying test, MMSE, BDS, BIMC, Raven's matrices, digit symbol, Rey's test |
| Notes |
Methodology briefly described |
